NCT04172818

Brief Summary

Allogenic hematopoietic stem cell transplantation is a specific time during hematological disease management for the patients, theirs relatives and the healthcare team. This heavy treatment is most of the time the last possible curative therapy and could cause many side effects such as infectious diseases and graft versus host reaction. The protective isolation is also a source of physical and psychological isolation. Published studies reported depressive syndrome, anxiety symptoms and post-traumatic stress disorders for patients and their families. Since 10 years ago, diaries are used in intensive care unit to limit these symptoms after a coma. In analogy, the diary for the patients with allogenic hematopoietic stem cell transplantation could be a mean to reduce the psychological adverse impact and long terms consequences. The investigators want to evaluate the psychological impact of a diary on the patients hospitalized for allogenic hematopoetic stem cell transplantation and on their relatives.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2019

Completed
13 days until next milestone

First Submitted

Initial submission to the registry

November 14, 2019

Completed
7 days until next milestone

First Posted

Study publicly available on registry

November 21, 2019

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2021

Completed
1.9 years until next milestone

Study Completion

Last participant's last visit for all outcomes

March 21, 2023

Completed
Last Updated

March 22, 2023

Status Verified

March 1, 2023

Enrollment Period

1.5 years

First QC Date

November 14, 2019

Last Update Submit

March 21, 2023

Conditions

Keywords

allogenic hematopoietic stem cell transplantationdiarypsychological disorders

Outcome Measures

Primary Outcomes (6)

  • Measure of diary impact on patient quality of life

    the diary for patients with allogenic hematopoietic stem cell transplantation could be a mean to reduce the psychological adverse impact and long term consequences.

    at day 0

  • Measure of diary impact on patient quality of life

    the diary for patients with allogenic hematopoietic stem cell transplantation could be a mean to reduce the psychological adverse impact and long term consequences.

    through the end of hospitalisation, an average of 3 weeks

  • Measure of diary impact on patient quality of life

    the diary for patients with allogenic hematopoietic stem cell transplantation could be a mean to reduce the psychological adverse impact and long term consequences.

    at 30 days after transplantation

  • Measure of diary impact on patient quality of life

    the diary for patients with allogenic hematopoietic stem cell transplantation could be a mean to reduce the psychological adverse impact and long term consequences.

    at day 100 after transplantation

  • Measure of diary impact on patient quality of life

    the diary for patients with allogenic hematopoietic stem cell transplantation could be a mean to reduce the psychological adverse impact and long term consequences.

    6 months after transplantation

  • Measure of diary impact on patient quality of life

    the diary for patients with allogenic hematopoietic stem cell transplantation could be a mean to reduce the psychological adverse impact and long term consequences.

    a year after transplantation

Secondary Outcomes (12)

  • Measure of diary impact on health care team satisfaction

    at day 0

  • Measure of diary impact on health care team satisfaction

    through the end of hospitalisation, an average of 3 weeks

  • Measure of diary impact on health care team satisfaction

    at 30 days after transplantation

  • Measure of diary impact on health care team satisfaction

    at day 100 after transplantation

  • Measure of diary impact on health care team satisfaction

    6 months after transplantation

  • +7 more secondary outcomes

Study Arms (1)

Patients with diary

EXPERIMENTAL

Evaluation the psychological impact of a diary on the patients hospitalized for allogenic hematopoetic stem cell transplantation and on their relatives.

Behavioral: quality of life questionnaire

Interventions

Since 10 years ago, diaries are used in intensive care unit to limit these symptoms after a coma.In analogy, the diary for patients with allogenic hematopoietic stem cell transplantation could be a mean to reduce the psychological adverse impact and long term consequences. The psychological impact of a diary on patients hospitalized for allogenic hematopoetic stem cell transplantation and on their relatives will be evaluated.

Patients with diary

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • patient age \> 18 years
  • patient hospitalized for an hematopoietic allogenic stem cell transplantation
  • patient agreeing to participate

You may not qualify if:

  • patient not hospitalized for an hematopoietic allogenic stem cell transplantation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU Amiens

Amiens, 80054, France

Location

MeSH Terms

Conditions

Hematologic NeoplasmsMental Disorders

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsHematologic DiseasesHemic and Lymphatic Diseases

Study Officials

  • Delphine Lebon, MD

    CHU Amiens

    PRINCIPAL INVESTIGATOR
  • Marie Beaumont, MD

    CHU Amiens

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 14, 2019

First Posted

November 21, 2019

Study Start

November 1, 2019

Primary Completion

May 1, 2021

Study Completion

March 21, 2023

Last Updated

March 22, 2023

Record last verified: 2023-03

Data Sharing

IPD Sharing
Will not share

Locations